Skip to content

GNPX

Genprex, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.50
+2.19%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue
Cost of Revenue6.7K15.0K25.6K
Gross Profit(6.7K)(15.0K)(25.6K)
Operating Expenses
R&D Expense9.8M9.4M10.5M17.6M11.5M
SG&A Expense6.0M6.1M10.6M13.4M12.3M
General & Admin Expense6.0M6.1M13.4M
Selling & Marketing Expense(3.00)
Other Expenses
Total Operating Expenses15.8M15.5M21.2M31.1M23.8M
Cost and Expenses15.8M15.5M21.2M31.1M23.8M
Operating Income (EBIT)(15.8M)(15.5M)(21.2M)(31.1M)(23.8M)
Non-Operating
Interest Income17.7K63.6K215.1K90.1K
Interest Expense455.5K739.9K
Net Interest Income(437.9K)(739.9K)63.6K215.1K90.1K
Other Non-Op Income/Expense(655.9K)(713.3K)63.0K215.1K90.1K
Non-Operating Income (excl Interest)(84.1K)(26.6K)(63.0K)(215.1K)(90.1K)
EBT (Pre-Tax Income)(16.5M)(16.2M)(21.1M)(30.9M)(23.7M)
Income Tax Expense
Bottom Line
Net Income(16.5M)(16.2M)(21.1M)(30.9M)(23.7M)
Earnings from Cont. Ops(16.5M)(16.2M)(21.1M)(30.9M)(23.7M)
Earnings from Discont. Ops
Bottom Line Net Income(16.5M)(16.2M)(21.4M)(30.9M)(23.7M)
Per Share
Basic EPS($158.78)($382.80)($5,872.98)($24,838.00)($21,780.00)
Diluted EPS($158.78)($382.80)($5,872.98)($24,816.00)($21,780.00)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding47316242397364212431089
Diluted Shares Outstanding47316242397364212431090
Profitability Metrics
EBITDA(15.8M)(15.5M)(21.1M)(30.8M)(23.7M)
D&A6.7K15.0K25.6K
EBIT(15.8M)(15.5M)(21.1M)(30.9M)(23.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026